Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method
about
Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolateCoxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entryThe HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55)Rhinoviruses and Respiratory Enteroviruses: Not as Simple as ABCAnti-infective immunoadhesins from plants.Crystal structure of two CD46 domains reveals an extended measles virus-binding surfaceDetermination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.Echovirus 7 entry into polarized intestinal epithelial cells requires clathrin and Rab7.Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus.Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2Role for beta2-microglobulin in echovirus infection of rhabdomyosarcoma cellsViral cell entry induced by cross-linked decay-accelerating factorCell adhesion molecules in the pathogenesis of and host defence against microbial infection.Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells.Sialic acid functions in enterovirus 70 binding and infectionCytolytic replication of echoviruses in colon cancer cell linesBordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin.Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).Characterization of the echovirus 7 receptor: domains of CD55 critical for virus bindingIdentification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus.Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cellsA knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins.Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor.The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor.Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence.Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.Fatty acid-depleted albumin induces the formation of echovirus A particles.Echoviruses bind heparan sulfate at the cell surface.Neuronal cell surface molecules mediate specific binding to rabies virus glycoprotein expressed by a recombinant baculovirus on the surfaces of lepidopteran cellsMajor and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms.A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts.A rapid and efficient method for studies of virus interaction at the host cell surface using enteroviruses and real-time PCR.Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B virusesEchovirus 1 replication, not only virus binding to its receptor, VLA-2, is required for the induction of cellular immediate-early genes.Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55).Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro.
P2860
Q24558693-AB1E3CB8-A3D3-4E90-9334-76D4DA342EE8Q24673735-3C19C99C-C977-4445-BE33-C19BF87836ACQ24682005-221ACFFC-4EBF-4B61-AE03-722E2DB5BDCAQ26772127-AFE06068-2D2A-4899-BD6C-29B03C29D92AQ26799080-5FD2EB3E-2C3D-4951-9402-628051EAEF24Q27618470-7B0CAC5B-B21F-4F62-AFBA-892241A57C14Q27639329-C402B8FF-C119-4CEA-ADD9-90D632B04481Q27639359-F83FBB28-F340-4DF3-913C-CEF0D6249D9BQ30427371-E8603E3E-7008-4C18-AA61-EACF0291924DQ31952001-20692476-8118-4679-B438-E60B31EA81DEQ33648918-63FAEE66-7A57-4580-922F-2E9218F06A0AQ33784850-081A0CC7-C0AE-4457-B698-05A3F17DEA6BQ33785545-513C7D1E-BF62-487A-BE26-635D4BC356F7Q33850097-46ED0999-C948-4F5E-8DD3-234F61FBA27EQ34344487-8BFA7779-D291-4DE1-BC8F-8AC2B5AC9653Q34355181-3587AAC1-569D-48F9-90ED-DB40A9A633FBQ35541517-23AA23B8-FB90-4F91-BD4E-134C65FE995EQ35554587-626A0BAE-994E-4623-865A-65E82E8E0E36Q35835449-DE268209-0EDC-42D6-9AFB-59FC15B404C0Q35845749-B0786A67-F941-4431-8C6B-0B4C95181C89Q35906814-286EDFC3-0736-4588-9632-94AAAD2D854FQ36509372-80320B3B-5162-4D2E-A2C9-E7285955CD96Q36549438-11429738-83D2-47AC-967D-1F4E976FE69EQ37451479-C0D69600-42F5-4282-9DBF-2FEA9B02C9C1Q37596657-B84C1F1A-C0F0-4C68-ACC9-227B5E37B780Q38335252-D2CAA537-BBFE-41F9-98B9-07F062DDC239Q38354701-0E2A569D-2D9F-42CD-BA3E-D56402A19A63Q39551034-8DF2E621-A64B-489B-A07B-52D2EE7EF357Q39582322-339427C6-7489-4755-A44E-B0D03E573DDEQ39590333-C422786B-8223-44BA-87FA-B858AD3561D7Q39602859-BADCB4CC-A56A-452C-BD26-15F33D4D8E9CQ39642201-AB01AE41-D29F-487E-AA05-C5BF0F04E71AQ39642336-E02762BD-133A-4025-A21C-72257C4AE743Q39684666-BC59E940-6E95-44E0-A7A2-6B3C078902AAQ39765999-85F7ECB9-E691-4BC6-897E-AF3596783585Q39872262-2D2C16E2-BE26-4F3F-A364-B90E8FC14ED8Q39879578-C0E17427-FD5A-403F-A4AE-8F0BC1752A60Q40015372-E9AE937C-B931-49E6-A447-FDFF41224E79Q40426040-205EB4DA-F93C-4594-92AE-ABD20B565B38Q51734249-58BF8B67-A641-41BA-AEC4-EBC9ED024E4D
P2860
Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@ast
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@en
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@en-gb
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@nl
type
label
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@ast
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@en
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@en-gb
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@nl
prefLabel
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@ast
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@en
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@en-gb
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@nl
P2093
P2860
P921
P1433
P1476
Decay-accelerating factor CD55 ...... id immuno-focal cloning method
@en
P2093
P2860
P304
P356
10.1002/J.1460-2075.1994.TB06836.X
P407
P577
1994-11-01T00:00:00Z